Kadcyla (ado-trastuzumab emtansine) - Roche
Elahere (mirvetuximab soravtansine-gynx) - AbbVie
Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Trodelvy (sacituzumab govitecan-hziy) - Gilead
Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
izalontamab brengitecan (BL-B01D1) - Sichuan Biokin Pharmaceutical, BMS, Systimmune
Meiyouheng (becotatug vedotin) - Lepu Biopharma
http://clinicaltrials.gov/ct2/show/NCT07825753
 
Sep 18, 2026
 
Prev Next